Nos encantaría que formes parte de nuestra comunidad. Únete a nuestro Discord para conectarte con nosotros y otros miembros!

Ticker
LH.MX

Price
5245.61
Stock movement up
+- (%)
Company name
Labcorp Holdings Inc.
Exchange
(MX
,
Currency
MXN
)
Sector
Healthcare >
Diagnostics & Research
Capitalización del mercado
434.86B
Valor de Ent
-
Precio/Ventas
-
Precio/Reservar
-
Rendimiento del div.
-
Crecimiento del div.
-
Años de crecimiento
-
Pago FCF
-
Seguimiento de P/E
-
P/E A plazo
-
PEG
-
EPS crecimiento
-
Rendimiento a 1 año
27.91%
Rendimiento a 3 años
-
Rendimiento a 5 años
-
Rendimiento a 10 años
-
Última actualización: 2025-11-21

DIVIDENDOS

LH.MX no paga dividendos

VALORACIÓN

Relaciones de valoración

Loading...
Datos de relaciones de valoración
Seguimiento de P/E-
Precio de OCF-
Precio de FCF-
Precio de EBITDA-
EV a EBITDA-

Valoración (ventas/valor contable)

Loading...
Datos de valoración (ventas/valor contable)
Precio de venta-
Precio para reservar-
EV a ventas-

FINANZAS

INFORMACIÓN SOBRE LAS ACCIONES

Gráfico de acciones

Loading...
Datos sobre el precio de las acciones
Abierto5245.61
Máximo diario5245.61
Mínimo diario5245.61
Volumen diario0K
Máximo histórico5559.07
Estimación de analistas a 1 año-
Beta0.97
EPS (TTM)-
Dividendo por acción0.00
Fecha ex-div28 Aug 2025
Próxima fecha de beneficios5 Feb 2026

Potencial de desventaja

Loading...
Datos del potencial de desventaja
LH.MXS&P500
Caída del precio actual desde el máximo histórico-5.64%-3.60%
La mayor caída de precio-26.23%-19.00%
Fecha de la mayor caída17 Feb 20258 Apr 2025
Caída promedio del máximo-15.03%-2.73%
Tiempo promedio para un nuevo máximo-6 days
Tiempo máximo hasta el nuevo máximo280 days89 days
DETALLES DE LA EMPRESA
LH.MX (Labcorp Holdings Inc.) company logo
Mercado
434.86B
Categoría de Mercado
Large-cap
Descripción
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
Empleados
70000
Relaciones con inversionistas
-
Archivos de la SEC
CEO
País
Mexico
Ciudad
Tipo de acciones
-
CCC estatus
-
Frecuencia de Dividendos
-
EVENTOS Y PRESENTACIONES
EventosPresentaciones
Loading...
ENTENDER EL NEGOCIO
Loading...
NOVEDADES DE LA EMPRESA
Todas las novedadesComunicados de prensa
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis' ex...
24 de noviembre de 2025
Labcorp Holdings (LH) is drawing attention after its Plasma Detect assay was featured in two respected medical journals. The company’s digital pathology joint initiative with Lunit also made headlines...
24 de noviembre de 2025
Even though Labcorp Holdings Inc. ( NYSE:LH ) posted strong earnings, investors appeared to be underwhelmed. We did...
7 de noviembre de 2025
Labcorp’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting investor concerns about profitability and future growth levers. Management attri...
4 de noviembre de 2025
OLATHE, Kan., November 03, 2025--KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment o...
3 de noviembre de 2025
OPKO Health recently reported third-quarter earnings with revenue of US$151.67 million and net income of US$21.63 million, surpassing analyst expectations, and announced a collaboration with Regeneron...
31 de octubre de 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
31 de octubre de 2025
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...
31 de octubre de 2025
Labcorp Holdings Inc (LH) reports a robust 9% revenue increase and a 19% rise in adjusted EPS, while navigating challenges in early development and currency impacts.
30 de octubre de 2025
Labcorp Holdings (LH) posted a net profit margin of 6.2% for the period, up from 3.4% a year ago, as earnings surged 96.4% year-over-year. This is well above the company's five-year average despite a ...
30 de octubre de 2025
Página siguiente